Reneural Technologies (fka CardioCrown), a Hatfield, UK-based provider of a neurorehabilitation platform, raised £475K in PreSeed funding.
The round, which was led by SFC Capital, with participation from undisclosed investors, was completed in conjunction with Innovate UK’s Investor Partnerships SME Round 7.
The company intends to use the funds to grow its VR therapy offerings and expand into mental health support for stroke survivors.
Led by CEO Victor Harabari, Reneural is an neurotech company addressing the critical needs of stroke survivors by offering a comprehensive Neurorehabilitation platform that integrates technologies including virtual reality (VR), robotics, electromyography (EMG), and functional electrical stimulation (FES). The platform is designed to improve patient outcomes, reduce healthcare costs, and ease the burden on clinicians by supporting remote care.
It is dedicated to closing the gap in continuous rehabilitation, with a focus on physical, visual, cognitive, and mental health therapies in a single, cohesive platform, ensuring personalised long-term care.
FinSMEs
07/11/2024